Detalhe da pesquisa
1.
Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study.
Ann Oncol
; 29(11): 2214-2222, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30215676
2.
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study.
Ann Oncol
; 29(6): 1409-1416, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668860
3.
A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.
Diabetes Obes Metab
; 16(2): 170-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23911196
4.
Pioglitazone in the treatment of NASH: the role of adiponectin.
Aliment Pharmacol Ther
; 32(6): 769-75, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20662773
5.
[Early experience with superselective vagotomy in the management of duodenal ulcer]. / Superselectiv vagotomiával szerzett korai tapasztalataink a duodenalis ulcus kezelésében.
Orv Hetil
; 125(37): 2231-6, 1984 Sep 09.
Artigo
em Húngaro
| MEDLINE | ID: mdl-6384885